Sanil Pharmaceuticals Private Limited

Sanil Pharmaceuticals Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U24239KA1989PTC010426 Incorporated 06 October 1989 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹9.45 Lakh
▼ 99.24% YoY
Net loss · FY 2025
₹11.74 Lakh
Net margin -124.2%
EBITDA · FY 2025
-₹11.73 Lakh
EBITDA margin -124.1%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹1.97 Cr
No open charges
Company age
37 yrs
Est. 1989
Employees · EPFO
6
Provident fund records

About Sanil Pharmaceuticals Private Limited

Data last updated:

Sanil Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 October 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA1989PTC010426. Its GSTIN is 29AABCS9810L1ZW (Karnataka).

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ishaan Pejavar Rao and Nandan Pejavar Rao.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.13/1(Old No.90/1) 18th Cross 19th Main 1st Block Rajaji Nagar, Bengaluru, Karnataka, India – 560010.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.45 Lakh. For the same year it recorded a net loss of ₹11.74 Lakh (net margin -124.2%) and EBITDA of -₹11.73 Lakh (EBITDA margin -124.1%). Revenue has declined at a compounded annual rate (CAGR) of 158% over three years and 42% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹1.97 Cr on record. Court records list 4 cases involving the company, including 4 filed against it.

Sanil Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0070741). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanilpharma.com.

Company details

CIN U24239KA1989PTC010426
Registration Number 010426
Incorporation Date 06 October 1989
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0070741

CIN history

Sanil Pharmaceuticals has one previous CIN (Corporate Identification Number): U02423KA1989PTC010426. The current CIN is U24239KA1989PTC010426, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239KA1989PTC010426Current
U02423KA1989PTC010426Previous
Key People
Ishaan Pejavar Rao Director Nandan Pejavar Rao Director Nilima Dayanand Rao Director

Recognitions & Rankings of Sanil Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-03-0070741

Contact details

Sanil Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka. Its website is sanilpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    sanilpharma.com
  • Registered Address
    No.13/1(Old No.90/1) 18th Cross 19th Main 1st Block Rajaji Nagar, Bengaluru, Karnataka, India – 560010
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sanil Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Sanil Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Sanil Pharmaceuticals Private Limited

FY 2025 filings available

Sanil Pharmaceuticals Private Limited reported revenue of ₹9.45 Lakh for FY 2025.

Revenue · FY 2025
₹9.45 Lakh
Net loss · FY 2025
₹11.74 Lakh margin -124.2%
EBITDA · FY 2025
-₹11.73 Lakh margin -124.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 158%
5 years · compounded
▼ 42%
EBITDA CAGR growth
3 years · compounded
▲ 43%
5 years · compounded
▼ 19%

Revenue has declined at a compounded annual rate (CAGR) of 42% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹11.73 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.74 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-124.1%
Net Profit Margin-124.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sanil Pharmaceuticals Private Limited, buy the company report.

Board of directors of Sanil Pharmaceuticals Private Limited

Sanil Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ishaan Pejavar Rao
Also directs: Surima Ventures LLP, Remidex Pharma Private Limited, Ishaan Labs Private Limited
Director24 Oct 20188 Years 0 MonthsCurrent
Nandan Pejavar Rao
Also directs: Surima Ventures LLP, Remidex Pharma Private Limited, Ishaan Labs Private Limited
Director24 Oct 20188 Years 0 MonthsCurrent
Nilima Dayanand Rao
Also directs: Surima Ventures LLP, Remidex Pharma Private Limited, Ishaan Labs Private Limited
Director30 Sep 199531 Years 1 MonthsCurrent
View all directors

Auditor

Sanil Pharmaceuticals Private Limited is audited by B. Shivananda Pai & Co for the financial year 2022.

Auditor firmFinancial yearFirm registration number
B. Shivananda Pai & CoFY 2022007020S

Shareholding

The shareholding of Sanil Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sanil Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.97 Cr
Breakdown by lending institutions
Canara Bank₹1.66 Cr
Karnataka State Financial Corporation₹0.18 Cr
Can Fin Homes Limited₹0.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jul 201510616058Canara Bank₹38.85 LakhSatisfied
31 Mar 201210354441Canara Bank₹6.88 LakhSatisfied
17 Jan 200390192647Canara Bank₹1 CrSatisfied
29 Oct 199790191865Can Fin Homes Limited₹13.5 LakhSatisfied
11 Jun 199790191825Canara Bank₹20 LakhSatisfied

To see the full charge records of Sanil Pharmaceuticals Private Limited, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sanil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sanil Pharmaceuticals Private Limited has a workforce of 6 employees on its EPFO records as of Mar 24, 2024, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1
Employee growth
-66.67%

GST

Sanil Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AABCS9810L1ZWKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Sanil Pharmaceuticals Private Limited, buy the company report.

Recent activity

Sanil Pharmaceuticals Private Limited has 7 board changes on record since 1995: 3 appointments and 4 cessations. The latest: Mohini Dayanand Rao ceased to be Director on 11 Jun 2020.

AGM
Sanil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sanil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Mohini Dayanand Rao ceased to be Director.
Ceased
Ishaan Pejavar Rao ceased to be Additional Director.
Ceased
Nandan Pejavar Rao ceased to be Additional Director.
Charges
A charge registered on 23 Jul 2015 via Charge ID 10616058 with Canara Bank was fully satisfied on 23 May 2019.
Appointed
Ishaan Pejavar Rao was appointed as Director.
Appointed
Nandan Pejavar Rao was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 38.85 Lakh with Charge ID 10616058 was registered on 23 Jul 2015.
Charges
A charge registered on 31 Mar 2012 via Charge ID 10354441 with Canara Bank was fully satisfied on 28 Feb 2015.
Charges
A charge registered on 29 Oct 1997 via Charge ID 90191865 with Can Fin Homes Limited was fully satisfied on 12 Jun 2012.
Charges
A charge with Canara Bank amounted to Rs. 6.88 Lakh with Charge ID 10354441 was registered on 31 Mar 2012.

12 earlier events are in the company report.

Frequently asked questions

Sanil Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 October 1989 (37+ years old) and is registered under CIN U24239KA1989PTC010426.

Sanil Pharmaceuticals has 3 current directors:

The latest financial statements of Sanil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sanil Pharmaceuticals is 29AABCS9810L1ZW, registered in Karnataka.

The CIN (Corporate Identification Number) of Sanil Pharmaceuticals is U24239KA1989PTC010426. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sanil Pharmaceuticals has 4 court cases on record: 4 filed against it. Most are in the high courts.

Sanil Pharmaceuticals was incorporated on 06 October 1989, making it 37+ years old. It is registered with the Registrar of Companies, Bangalore.

Mohini Dayanand Rao ceased to be Director on 11 Jun 2020. Ishaan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Nandan Pejavar Rao ceased to be Additional Director on 24 Sep 2019. Sanil Pharmaceuticals has 7 board changes on record in total.

Yes, Sanil Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0070741).

Sanil Pharmaceuticals can be reached through the website sanilpharma.com. Its registered office is in Bengaluru, Karnataka, India.